A Clinical Trial to Evaluate the Effects of an Omega-3-containing Supplement on DHA and EPA Levels in the Blood

Part of paid clinical trials in Las Vegas, Nevada.

Sponsor
Revive Active
Study ID
NCT07753174
Status
Recruiting

Conditions

  • Cardiovascular Health
  • Cognitive Health
  • DHA and EPA Blood Levels
  • Omega-3 Deficiency

Eligibility Criteria

Sex
ALL
Age
18 Years - 65 Years
Healthy Volunteers
Accepted

Interventions

  • Omega Active Supplement — DIETARY_SUPPLEMENT
    All participants receive one dose (two capsules) of the Omega Active omega-3 supplement daily for 12 weeks.

Study Details

This is a 12-week, hybrid, single-arm clinical trial designed to evaluate the effects of an omega-3-containing supplement (Omega Active) on DHA and EPA levels in the blood. Forty participants will take two capsules of the test product daily and complete study-specific questionnaires at Baseline, Week 4, Week 8, and Week 12, while also attending their local Quest Diagnostics Center at Baseline and Week 12 for blood biomarker testing. The study will also assess participants' perceptions of the effects of the test product on cognitive performance, gastrointestinal symptoms, and overall health through self-reported questionnaires. There is no randomization or blinding; all participants will receive the active supplement for the full 12-week intervention period.

Key Dates

First listed
Aug 7, 2026
Start date
Sep 30, 2026
Status verified
Aug 2026
Primary completion
Dec 31, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
49 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Omega Active Supplement

Primary Outcome Measure

Change in DHA levels in the blood [ Time Frame: Baseline and Week 12 ]

Central Contacts

  • Patrick Renner
    4242450284

Locations (1)

FacilityCityStateZIPSite coordinators
CitruslabsLas VegasNevada89101-

Find similar trials in Las Vegas, NV

Related Studies